Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics

被引:14
|
作者
Misawa, N
Matsumoto, A
Tanaka, E
Rokuhara, A
Yoshizawa, K
Umemura, T
Maki, N
Kimura, T
Kiyosawa, K
机构
[1] Shinshu Univ, Sch Med, Dept Med, Matsumoto, Nagano 3908621, Japan
[2] Adv Life Sci Inst Inc, Wako, Saitama, Japan
[3] Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan
关键词
HBV DNA; seroconversion; HBV core-related antigen; precore mutation; core promoter mutation;
D O I
10.1002/jmv.20505
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The characteristic differences between patients with and without loss of hepatitis B virus (HBV) DNA after achieving hepatitis B e antigen seroconversion were analyzed by comparing changes in HBV DNA and HBV core-related antigen levels during a period from 3 years before to 3 years after the seroconversion. Of the 24 seroconverters, 6 (inactive replication group) showed continuous loss of HBV DNA in serum after the seroconversion and the remaining 18 did not lose HBV DNA (active replication group). The HBV DNA level was similar between the two groups, while the HBV core-related antigen level was significantly lower in the active replication group than in the inactive replication group before the seroconversion. The levels of both HBV DNA and HBV core-related antigen decreased remarkably around the time of seroconversion in the inactive replication group, while these levels did not change or decreased slightly in the active replication group. After the seroconversion, the HBV DNA level was significantly higher in the active replication group than in the inactive replication group, while the HBV core-related antigen level was similarly low between the two groups. Because the serum level of HBV core-related antigen mainly reflects that of HBe antigen, the low level of HBV core-related antigen seen after seroconversion in both groups might have contributed to the occurrence of seroconversion. The precore and core promoter mutations which cause diminished excretion of hepatitis B e antigen were significantly more frequent in the active replication group than in the inactive replication group. It was therefore considered that the seroconversion was caused mainly by a decrease in viral replication in the inactive replication group, and mainly by a decrease in HBe antigen production in the active replication group.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [41] Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B
    Wu, I-Chin
    Chow, Nan-Haw
    Cheng, Pin-Nan
    Liu, Wen-Chun
    Young, Kung-Chia
    Chang, Wei-Lun
    Chen, Chi-Yi
    Tseng, Kuo-Chih
    Chang, Ting-Tsung
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (06) : 663 - 669
  • [42] Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus
    Adil, B.
    Fatih, O.
    Volkan, I.
    Bora, B.
    Veysel, E.
    Koray, K.
    Cemalettin, K.
    Burak, I.
    Sezai, Y.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2119 - 2123
  • [43] Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus
    Maylin, Sarah
    Boyd, Anders
    Martinot-Peignoux, Michelle
    Delaugerre, Constance
    Bagnard, Georges
    Lapalus, Martine
    Zoulim, Fabien
    Lavocat, Fabien
    Marcellin, Patrick
    Simon, Francois
    Girard, Pierre-Marie
    Lacombe, Karine
    JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (04) : 306 - 311
  • [44] Association between single-nucleotide polymorphisms and early spontaneous hepatitis B virus e antigen seroconversion in children
    Komatsu H.
    Murakami J.
    Inui A.
    Tsunoda T.
    Sogo T.
    Fujisawa T.
    BMC Research Notes, 7 (1)
  • [45] HBV DNA Level as an Important Determinant of E Antigen Seroconversion of Chronic Hepatitis B during Adefovir Dipivoxil Therapy
    Tseng, Kuo-Chih
    Cheng, Pin-Nan
    Wu, I-Chin
    Chang, Chin-Kuo
    Chou, An-Liang
    Liu, Wen-Chun
    Chang, Ting-Tsung
    HEPATO-GASTROENTEROLOGY, 2009, 56 (91-92) : 813 - 818
  • [46] The hepatitis B virus reactivation after transarterial chemoembolization in Chinese hepatocellular carcinoma patients with low serum hepatitis B virus DNA level
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1367 - 1370
  • [47] Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
    Lok, Anna S.
    Zoulim, Fabien
    Dusheiko, Geoffrey
    Chan, Henry L. Y.
    Buti, Maria
    Ghany, Marc G.
    Gaggar, Anuj
    Yang, Jenny C.
    Wu, George
    Flaherty, John F.
    Subramanian, G. Mani
    Locarnini, Stephen
    Marcellin, Patrick
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (01) : 8 - 20
  • [48] Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients
    Broquetas, Teresa
    Garcia-Retortillo, Montserrat
    Mico, Miquel
    Canillas, Lidia
    Puigvehi, Marc
    Canete, Nuria
    Coll, Susana
    Viu, Ana
    Hernandez, Juan Jose
    Bessa, Xavier
    Carrion, Jose A.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (11) : 1076 - 1088
  • [49] Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues
    Wong, Grace L-H
    Chan, Henry L-Y
    Lo, Angeline O-S
    Chan, Hoi-Yun
    Tse, Chi-Hang
    Chim, Angel M-L
    Wong, Vincent W-S
    ANTIVIRAL THERAPY, 2013, 18 (08) : 979 - 986
  • [50] Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive
    Shin, Jung Woo
    Park, Neung Hwa
    Jung, Seok Won
    Kim, Byung Chul
    Kwon, Sung Ho
    Park, Jae Serk
    Jeong, In Du
    Bang, Sung-Jo
    Kim, Do Ha
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (41) : 6693 - 6698